Project Description

  • ECW Covered Oesophageal Stent
  • ECW Covered Oesophageal Stent
  • ECW Covered Oesophageal Stent
  • ECW Covered Oesophageal Stent

ECW Covered Oesophageal Stent

Indication: For application in palliative treatment of cardiac stricture caused by malignant tumours. CE mark for benign indications – can be safely removed within 4 weeks of placement.

  • Anti-reflux ‘S’ valve is attached inside the stent to help manage gastro oesophageal reflux

  • Large 28mm shoulder diameter to reduce stent migration

  • Inner silicone covering enabling food and liquid to easily pass

  • Outer silicone flange to enhance patency and resist tumour in-growth

  • 12 gold radiopaque markers provide high visibility under fluoroscopic visualisation – proximal/central/distal

  • Proximal and distal lasso to aid accurate re-positioning and retrieval

Product Code Description Stent (mm) Delivery Device Box Size
Usable Length Total Length Diameters Length (cm) Diameter (mm/Fr)
ECW22090-Z070 HANAROSTENT® Covered Oesophageal Stent 50 90 28-22-28 70 8 / 24 1
ECW22120-Z070 HANAROSTENT® Covered Oesophageal Stent 80 120 28-22-28 70 8 / 24 1
ECW22160-Z070 HANAROSTENT® Covered Oesophageal Stent 120 160 28-22-28 70 8 / 24 1
Master Catalogue

Related Products